Marked transfection enhancement by the DPL (DNA/peptide/lipid) complex

International Journal of Molecular Medicine

Volumn 20, Issue 4, 2007, Pages 429-437

  Moon, I K Jae ^a   Kang, Hyungu ^a   Seu, Young Bae ^b   Chang, Byeong Churl ^c   Song, Dae Kyu ^c   Park, Jong Gu ^a,c  

^a WelGENE Inc   (South Korea)

^b Kyungpook National University   (South Korea)

^c Keimyung University School of Medicine   (South Korea)

Author keywords

Cationic lipids; Cysteine modification; Gene delivery; K ras antisense; Lipid complex; Tat peptide; Transfection

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA; LUCIFERASE; PEPTIDE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID METABOLISM; MALE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; SERUM; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DNA; GENE PRODUCTS, TAT; HIV-1; HUMANS; LIPID METABOLISM; LUCIFERASES; MALE; MICE; MICE, NUDE; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDES; SERUM; TRANSFECTION;

EID: 38449114257     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.4.429     Document Type: Article

References (37)

1. Pouton CW and Seymour LW: Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46: 187-203, 2001.
2. Akhtar S, Hughes MD, Khan A, Bibby M, Hussain M, Nawaz Q, Double J and Sayyed P: The delivery of antisense therapeutics. Adv Drug Deliv Rev 44: 3-21, 2000.
3. Lebedeva I, Beimetskaya L, Stein CA and Vilenchik M: Cellular delivery of antisense oligonucleotides. Eur J Pharm Biopharm 50: 101-119, 2000.
4. Ghaumont CG, Seksek O, Grzybowska J, Borowski E and Bolard J: Delivery systems for antisense oligonucleotides. Pharmacol Ther 87: 255-277, 2000.
5. Kataoka K and Harashima H: Gene delivery systems: viral vs. non-viral vectors. Adv Drug Deliv Rev 52: 151, 2001.
6. Wang II and Huang II: Adenovirus technology for gene manipulation and functional studies. Drug Discov Today 5: 10-16, 2000.
7. Luo D and Salzman WM: Synthetic DNA delivery systems. Nat Biotechnol 18: 33-37, 2000.
8. Brokx R and Gariepy J: Peptide- and polymer-based gene delivery vehicles. Methods Mol Med 90: 139-160, 2004.
9. Jordan M and Wurm F: Transfection of adherent and suspended cells by calcium phosphate. Methods 33: 136-143, 2004.
10. Banga AK and Prausnitz MR: Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. Trends Biotechnol 16: 408-412, 1998.
11. Fulka J Jr, Loi P, Fulka H, Ptak G and Nagai T: Nucleus transfer in mammals: noninvasive approaches for the preparation of cytoplasts. Trends Biotechnol 22: 279-283, 2004.
12. Washbourne P and McAllister AK: Moving on to the cargo problem of microtubule-dependent motors in neurons. Curr Opin Neurobiol 12: 566-573, 2002.
13. Zelphati O, Uyechi LS, Barron LG and Szoka FC Jr: Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim Biophys Acta 1390: 119-133, 1998.
14. Morris MC, Chaloin L, Heitz F and Divita G: Translocating peptides and proteins and their use for gene delivery. Curr Opin Biotechnol 11: 461-466, 2000.
15. Schwarz JJ and Zhang S: Peptide-mediated cellular delivery. Curr Opin Mol Ther 2: 162-167, 2000.
16. Vives E, Brodin P and Lebleu B: A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010-16017, 1997.
17. Schwarze SR, Ho A, Vocero-Akbani A and Dowdy SF: In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285: 1569-1572, 1999.
18. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inoguchi H, Fujita S, Hayakawa T, Takeda K, Hasegawa M and Nakanishi M: Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 276: 26204-26210, 2001.
19. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K and Sugiura Y: Arginine-rich peptides. J Biol Chem 276: 5836-5840, 2001.
20. Torchilin VP, Rammohan R, Weissig V and Levchenkol TS: TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 98: 8786-8791, 2001.
21. Zanta MA, Valladier PB and Behr JP: Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 96: 91-96, 1999.
22. Ludtke JJ, Zhang G, Sebestyen MG and Wolff JA: A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J Cell Sci 112: 2033-2041, 1999.
23. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G and Prochiantz A: Cell internalization of the third helix of the Antennapedia homeoprotein is receptor-independent. J Biol Chem 271: 18188-18193, 1996.
24. Dokka S, Toledo D, Shi X, Ye J and Rojanasakul Y: High-efficiency gene transfection of macrophages by lipoplexes. Int J Pharm 206: 97-104, 2000.
25. Sorgi FL, Bhattacharya S and Huang L: Protamine sulfate enhances lipid-mediated gene transfer. Gene Therapy 4: 961-968, 1997. (Pubitemid 27437722)
26. Bharath MM, Chandra NR and Rao MR: Prediction of an HMG-box fold in the C-terminal domain of histone H1: insights into its role in DNA condensation. Proteins 49: 71-81, 2002.
27. Moon IJ, Choi K, Kim JE, Lee Y, Schreiber AD and Park JG: Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb. J Biol Chem 275: 4647-4653, 2000.
28. Yang Y, Ma J, Song Z and Wu M: HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors. FEBS Lett 532: 36-44, 2002.
29. Silhol M, Tyagi M, Giacca M, Lebleu B and Vives E: Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 269: 494-501, 2002.
30. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B and Barsoum J: Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91: 664-668, 1994.
31. Turner JJ, Arzumanov AA and Gait MJ: Synthesis, cellular uptake and HIV-1 Tat-dependent transactivation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucleic Acids Res 33: 27-42, 2005.
32. Moulton HM, Nelson MH, Hatlevig SA, Reddy MT and Iversen PL: Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides. Bioconjug Chem 15: 290-299, 2004.
33. Moon IJ, Lee Y, Kwak CS, Lee JH, Choi K, Schreiber AD and Park JG: Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb. Biochem J 346: 295-303, 2000.
34. Matsuda M, Park JG, Hunter S, Chien P and Schreiber AD: Abrogation of the Fc gamma receptor IIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides. Mol Biol Cell 7: 1095-1106, 1996.
35. Lee HJ and Pardridge WM: HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain micro-vascular endothelial cells. Bioconjug Chem 12: 995-999, 2001.
36. Avraham HK, Jiang S, Lee TH, Prakash O and Avraham S: HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells. J Immunol 173: 6228-6233, 2004.
37. Wheeler CJ, Felgner PL, Tsai YJ, Marshall J, Sukhu L, Doh SG, Hartikka J, Nietupski J, Manthorpe M, Nichols M, Plewe M, Liang X, Norman J, Smith A and Cheng SH: A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci USA 93: 11454-11459, 1996.